Capital International Inc’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $9.07M | Buy |
376,556
+2,270
| +0.6% | +$59.4K | 0.06% | 202 |
|
|
2026
Q1 | $10.5M | Buy |
374,286
+21,130
| +6% | +$563K | 0.08% | 188 |
|
|
2025
Q4 | $8.79M | Buy |
353,156
+228,051
| +182% | +$5.75M | 0.07% | 213 |
|
|
2025
Q3 | $3.19M | Hold |
125,105
| – | – | 0.03% | 255 |
|
|
2025
Q2 | $3.03M | Sell |
125,105
-78,000
| -38% | -$1.82M | 0.03% | 245 |
|
|
2025
Q1 | $5.15M | Sell |
203,105
-146,548
| -42% | -$3.83M | 0.06% | 207 |
|
|
2024
Q4 | $9.28M | Buy |
349,653
+33,489
| +11% | +$908K | 0.11% | 179 |
|
|
2024
Q3 | $9.15M | Sell |
316,164
-213,846
| -40% | -$6.24M | 0.12% | 165 |
|
|
2024
Q2 | $14.8M | Sell |
530,010
-14,498
| -3% | -$399K | 0.2% | 126 |
|
|
2024
Q1 | $15.1M | Sell |
544,508
-165,963
| -23% | -$4.61M | 0.2% | 134 |
|
|
2023
Q4 | $20.5M | Buy |
710,471
+245,806
| +53% | +$7.43M | 0.32% | 97 |
|
|
2023
Q3 | $15.4M | Buy |
464,665
+22,323
| +5% | +$789K | 0.3% | 102 |
|
|
2023
Q2 | $16.2M | Sell |
442,342
-15,233
| -3% | -$593K | 0.29% | 100 |
|
|
2023
Q1 | $18.7M | Buy |
457,575
+5,176
| +1% | +$224K | 0.38% | 78 |
|
|
2022
Q4 | $23.2M | Buy |
452,399
+25,957
| +6% | +$1.24M | 0.5% | 59 |
|
|
2022
Q3 | $18.7M | Sell |
426,442
-486,075
| -53% | -$23.6M | 0.42% | 74 |
|
|
2022
Q2 | $47.8M | Sell |
912,517
-78,591
| -8% | -$4M | 0.66% | 50 |
|
|
2022
Q1 | $51.3M | Buy |
991,108
+764,761
| +338% | +$39.7M | 0.57% | 67 |
|
|
2021
Q4 | $13.4M | Buy |
226,347
+7,214
| +3% | +$357K | 0.12% | 152 |
|
|
2021
Q3 | $9.43M | Sell |
219,133
-14,536
| -6% | -$644K | 0.09% | 161 |
|
|
2021
Q2 | $9.15M | Sell |
233,669
-159,298
| -41% | -$6.19M | 0.08% | 168 |
|
|
2021
Q1 | $14.2M | Sell |
392,967
-100,507
| -20% | -$3.57M | 0.13% | 145 |
|
|
2020
Q4 | $18.2M | Buy |
493,474
+29,988
| +6% | +$1.1M | 0.17% | 130 |
|
|
2020
Q3 | $16.1M | Buy |
463,486
+148,422
| +47% | +$5.2M | 0.18% | 125 |
|
|
2020
Q2 | $9.78M | Buy |
315,064
+122,413
| +64% | +$4.16M | 0.12% | 138 |
|
|
2020
Q1 | $5.97M | Buy |
192,651
+68,290
| +55% | +$2.33M | 0.1% | 131 |
|
|
2019
Q4 | $4.62M | Buy |
124,361
+57,375
| +86% | +$2.04M | 0.06% | 139 |
|
|
2019
Q3 | $2.28M | Sell |
66,986
-4,770
| -7% | -$173K | 0.03% | 160 |
|
|
2019
Q2 | $2.95M | Buy |
71,756
+60,383
| +531% | +$2.4M | 0.21% | 102 |
|
|
2019
Q1 | $458K | Buy |
+11,373
| New | +$455K | 0.05% | 148 |
|
|
2017
Q4 | – | Sell |
-4,743
| Closed | -$161K | – | 167 |
|
|
2017
Q3 | $161K | Sell |
4,743
-21,080
| -82% | -$678K | 0.02% | 149 |
|
|
2017
Q2 | $823K | Buy |
25,823
+843
| +3% | +$26.6K | 0.12% | 108 |
|
|
2017
Q1 | $811K | Sell |
24,980
-2,002
| -7% | -$63.1K | 0.1% | 118 |
|
|
2016
Q4 | $831K | Buy |
26,982
+20,342
| +306% | +$621K | 0.1% | 121 |
|
|
2016
Q3 | $213K | Hold |
6,640
| – | – | 0.03% | 125 |
|
|
2016
Q2 | $222K | Hold |
6,640
| – | – | 0.03% | 125 |
|
|
2016
Q1 | $187K | Buy |
6,640
+1,159
| +21% | +$33.1K | 0.02% | 122 |
|
|
2015
Q4 | $168K | Hold |
5,481
| – | – | 0.01% | 123 |
|
|
2015
Q3 | $163K | Buy |
5,481
+1,160
| +27% | +$37.2K | 0.01% | 121 |
|
|
2015
Q2 | $137K | Buy |
4,321
+421
| +11% | +$13.7K | 0.01% | 127 |
|
|
2015
Q1 | $129K | Hold |
3,900
| – | – | 0.01% | 123 |
|
|
2014
Q4 | $115K | Buy |
3,900
+633
| +19% | +$18.1K | 0.01% | 121 |
|
|
2014
Q3 | $92K | Buy |
+3,267
| New | +$91.7K | 0.01% | 115 |
|
Other funds holding PFE
Capital International Inc's PFE Position: Q2 2026 in Review
Capital International Inc increased its Pfizer (PFE) stake by 0.61% in Q2 2026, buying an estimated $59.4K and bringing the position to 376,556 shares worth $9.07M. The position accounts for 0.06% of the portfolio, ranked #202.
Capital International Inc first reported a position in PFE in Q3 2014 and has held it in 43 quarters since. The position peaked at $51.3M in Q1 2022. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Capital International Inc held 376,556 shares of Pfizer worth $9.07M as of Q2 2026.
- Capital International Inc bought 2,270 Pfizer shares in Q2 2026, an estimated $59.4K.
- Pfizer made up 0.06% of Capital International Inc's portfolio in Q2 2026, its #202 holding.
- Capital International Inc first reported a position in Pfizer in Q3 2014 and has held it in 43 quarters since.
- Capital International Inc's Pfizer position peaked at $51.3M in Q1 2022.
- 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Capital International Inc's 13F filing for Q2 2026, filed 12 Aug 2026.